PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
SLDB Solid Biosciences
- 4.0300
- +0.0900+2.28%
Close Feb 14 16:00 ET
- 4.1483
- +0.1183+2.94%
Post 20:01 ET
161.02MMarket Cap-1.33P/E (TTM)
4.2450High3.9200Low1.01MVolume3.9600Open3.9400Pre Close4.10MTurnover5.39%Turnover RatioLossP/E (Static)39.95MShares15.050052wk High0.96P/B75.44MFloat Cap2.880052wk Low--Dividend TTM18.72MShs Float822.6000Historical High--Div YieldTTM8.25%Amplitude1.8100Historical Low4.0630Avg Price1Lot Size
About Solid Biosciences Company
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Company Profile
SymbolSLDB
Company NameSolid Biosciences
Listing DateJan 26, 2018
Issue Price16.00
Founded2013
CEOMr. Alexander G. Cumbo
MarketNASDAQ
Employees88
Fiscal Year Ends12-31
Address500 Rutherford Avenue,3rd floor
CityCharlestown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-337-4680
Websitehttp://www.solidbio.com
Company Executives
- Name
- Position
- Salary
- Alexander G. Cumbo
- President, Chief Executive Officer and Director
- 918.55K
- Kevin Tan
- Treasurer, Chief Financial Officer and Principal Accounting Officer
- 1.35M
- Dr. Gabriel Brooks, M.D.
- Chief Medical Officer
- --
- Dr. Jessie Hanrahan, PhD
- Chief Regulatory Officer
- --
- Dr. Jennifer Marlowe, PhD
- Chief Scientific Officer
- --
- Dr. Paul Herzich, PhD
- Chief Technology Officer
- --
- David Tyronne Howton
- Chief Operating Officer, General Counsel and Secretary
- 648.88K
- Ian F. Smith
- Executive Chairman of the Board
- 828.65K
- Ilan Ganot
- Director
- 902.09K
- Rajeev Shah
- Independent Director
- 104.22K
- Dr. Clare Kahn, PhD
- Independent Director
- 105.72K
- Dr. Adam M. Koppel, M.D.,PhD
- Independent Director
- 94.22K
- Dr. Sukumar Nagendran, M.D.
- Independent Director
- 106.72K
- Dr. Georgia Keresty, M.P.H.,PhD
- Independent Director
- 101.72K
- Adam Stone
- Lead Independent Director
- 109.72K
- Dr. Martin Freed, F.A.C.P.,M.D.
- Independent Director
- 114.22K
- Lynne Sullivan
- Independent Director
- 113.22K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025